By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Swedish Orphan Biovitrum 

SE-112

  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Swedish Orphan Biovitrum Signs Manufacturing Agreements With Pfizer (PFE) 4/29/2016 9:36:04 AM
Swedish Orphan Biovitrum Publishes Its Report For The First Quarter 2016 4/27/2016 9:03:00 AM
Swedish Orphan Biovitrum Publishes 2015 Annual Report 4/27/2016 8:28:31 AM
Swedish Orphan Biovitrum Release: Orfadin Oral Suspension Approved In The U.S. 4/26/2016 10:23:20 AM
Swedish Orphan Biovitrum Signs Licensing Agreement With Affibody For IL-1 4/22/2016 8:52:31 AM
Swedish Orphan Biovitrum Release: European Patent Granted On New Formulation Of Kineret (Anakinra) 4/21/2016 9:23:01 AM
Invitation - Presentation Of Swedish Orphan Biovitrum's First Quarter Results 2016 4/19/2016 10:20:50 AM
Swedish Orphan Biovitrum Updates Outlook For 2016 2/29/2016 9:46:56 AM
Swedish Orphan Biovitrum And Biogen (BIIB) Receive Positive Opinion From CHMP For Alprolix (rFIXFc) For The Treatment Of Hemophilia B 2/26/2016 10:01:58 AM
Swedish Orphan Biovitrum To Initiate Clinical Development Programs In Acute Gout And Still's Disease, And Receives U.S. Patent On New Formulation For Kineret (Anakinra) 2/23/2016 9:22:08 AM
12345678910
//-->